The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S. Søgaard, Martin Tolstrup|PLoS Pathogens|2015Cited by 522
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021Steven G. Deeks, Josephine Nabukenya, Sharon R. Lewin et al.|Nature Medicine|2021Cited by 367
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meetingBoris Jülg, Bruce D. Walker, Lynda Dee et al.|The Lancet HIV|2019Cited by 206
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Mariane Høgsbjerg Schleimann et al.|Clinical Infectious Diseases|2017Cited by 146
Risk and Prognosis of Bloodstream Infections among Patients on Chronic Hemodialysis: A Population-Based Cohort StudyLars Dalgaard, Ole S. Søgaard|PLoS ONE|2015Cited by 79